Home | 2003 (1997-2003) Cover Shorty | Inside cover | News 11-04 | News 6-04 | Current stock holdings | Election results | Stock from the company | Stock givers /traders | Profit and loss | Balance sheet 2003 | Balance sheet 2000 | RE, S&U, bank stmts 2003 | RE, S&U, bank stmts 2000 | News & history first half 2004 | Dr. Peebles' story | News & history 2001 - 2003 | News & history 1997 - 2000 | Owners like Pfizer strategy | Wal-Mart strategy | Pedi-sales strategy | Celgene takeover of pediatric drugs strategy | Device maker strategy | Your choice for licensing strategies | Ballot | Expenses graph | Expense report 2003 | Goodwill report 2003 | Contacts
Prophy Research Corporation reports
RE, S&U, bank stmts 2000

Statement of Retained Earnings
Prophy Research Corporation
Years 1996-2000
(in dollars)
2000 1999 1998 1997 1996
Balance of retained earnings -56,775 -55,448 -53,864 -50,627 -49,524
or (loss) at year beginning
+ or - earnings or (loss) -1,284 -1,327 -1,584 -3,237 -1,103
during year
Balance of retained earnings -58,059 -56,775 -55,448 -53,864 -50,627
or (loss) at year end
                           
Sources and Uses of Funds
Sources of funds
Cash from stockholders 1,259 1,552 1,147 3,752 998
Cash decrease 25 0 437 0 105
Total sources 1,284 1,552 1,584 3,752 1,103
Uses of funds
Cash expenses 1,284 1,327 1,584 3,237 1,103
Cash increase 0 225 0 515 0
Total uses 1,284 1,552 1,584 3,752 1,103
                           
Bank Statement
Cash (Ray's pocket) 0 0 0 0 0
Bank (corporate account) 1,077 1,102 877 1,314 799
Total cash 1,077 1,102 877 1,314 799

On to the next page (news - a slightly fuller version of what you've already seen - first half 2004)